Get Our Top Trade Ideas Delivered Daily - 65% Off Now

+ New Watchlist

Benzinga Research

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

CureVac

CVACNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$3.15

0.061.94%

Last update: 2:36 PM

15 minutes delayed

CureVac (CVAC) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for CureVac (NASDAQ:CVAC) Stock

CureVac Stock (NASDAQ: CVAC)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, September 16, 2024

JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk

Friday, September 13, 2024

CureVac shares are trading higher after the c...
Benzinga Newsdesk
CureVac's CVGBM Cancer Vaccine Induces Immune...
Benzinga Newsdesk

Thursday, September 12, 2024

GSK Reveals 'Positive' Data From Mid-Stage Study Of Seasonal Influenza mRNA Vaccine
Vandana Singh
Earlier Today, GSK Announced Headline Results...
Benzinga Newsdesk

Friday, August 16, 2024

JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk

Thursday, August 15, 2024

CureVac Q2 Sales €14.400M May Not Be Comparab...
Benzinga Newsdesk
CureVac Advances Cancer Vaccine Candidate CVG...
Benzinga Newsdesk

Thursday, July 11, 2024

CureVac Announced The Latest Trial Dates For ...
Benzinga Newsdesk

Wednesday, July 03, 2024

JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Vandana Singh
CureVac shares are trading higher after the c...
Benzinga Newsdesk
CureVac Secures €400M Upfront and Up to €1.05...
Benzinga Newsdesk
CureVac Restructures to Focus on High-Value m...
Benzinga Newsdesk
GSK and CureVac Restructure Partnership, Focu...
Benzinga Newsdesk

Tuesday, June 18, 2024

Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor

Thursday, June 06, 2024

First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
Natan Ponieman

Wednesday, June 05, 2024

'First-ever human death of bird flu strain H5...
Benzinga Newsdesk
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor

Tuesday, May 28, 2024

CureVac Has Dosed The First Participant In Ph...
Benzinga Newsdesk

Thursday, May 23, 2024

CureVac's Cash And Cash Equivalents Position ...
Benzinga Newsdesk
CureVac Reported Q1 2024 Pre-Tax Loss Of €69....
Benzinga Newsdesk
CureVac Q1 2024 Sales €12.400M Beat €12.030M ...
Benzinga Newsdesk

Wednesday, May 22, 2024

Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor

Friday, May 17, 2024

Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
Avi Kapoor

Thursday, May 09, 2024

Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Shanthi Rexaline

Monday, May 06, 2024

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Avi Kapoor

Friday, April 26, 2024

COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Vandana Singh

Thursday, April 25, 2024

CureVac shares are trading lower after Leerin...
Benzinga Newsdesk
Leerink Partners Downgrades CureVac to Market...
Benzinga Newsdesk

Wednesday, April 24, 2024

CureVac shares are trading lower after the co...
Benzinga Newsdesk
CureVac Has Started The Phase 1 Part Of A Com...
Benzinga Newsdesk
CureVac And GSK Will End The Pandemic Prepare...
Benzinga Newsdesk
CureVac Is Implementing In 2024 An Organizati...
Benzinga Newsdesk
CureVac's Cash And Cash Equivalents Position ...
Benzinga Newsdesk
CureVac Q4 Sales €22.600M Miss €33.744M Estim...
Benzinga Newsdesk

Tuesday, April 16, 2024

CureVac And MD Anderson Enter Strategic Colla...
Benzinga Newsdesk

Friday, April 12, 2024

Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
Caleb Naysmith

Friday, April 05, 2024

Guggenheim Reiterates Neutral on CureVac
Benzinga Newsdesk

Thursday, April 04, 2024

CureVac, GSK Partner Release Data On Influenza Vaccine Study
Vandana Singh
CureVac Announces Phase 2 Interim Data from S...
Benzinga Newsdesk

Wednesday, January 17, 2024

CureVac Disclosed CEO Alexander Zehnder, Rece...
Benzinga Newsdesk

Friday, January 05, 2024

Why Biopharmaceutical Player CureVac Shares Are Rising Today
Nabaparna Bhattacharya
CureVac Unveils Positive Phase 2 Interim Data...
Benzinga Newsdesk

Tuesday, December 19, 2023

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
CureVac shares are trading lower after the co...
Benzinga Newsdesk
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
Vandana Singh
Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
Avi Kapoor

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved